|
 |
Spiriva HandihalerThis page contains recent news articles, when available, and an overview of Spiriva Handihaler but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Boehringer Ingelheim Pharmaceuticals Inc. and Pfizer Inc. said Thursday the Food and Drug Administration approved Spiriva HandiHaler as a treatment for ... BusinessWeek Spiriva HandiHaler Approved for the Reduction of COPD Exacerbations - Dec 22, 2009 How many of you use Spiriva HandiHaler for long-term maintenance treatment of your COPD? Now, there's is one more reason to continue to do so. ... About - News & Issues (blog) FDA Approves SPIRIVA HandiHaler For The Reduction Of COPD - Dec 21, 2009 Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc announced recently that the US Food and Drug Administration (FDA) has approved SPIRIVA HandiHaler ... BioResearch Online (press release) FDA panel: Gilead Sciences drug to treat deadly lung infection appears safe ... - Dec 10, 2009 ...voted 11-1 in favor of new labeling about the benefits of Boehringer Ingelheim's Spiriva Handihaler, which is approved to treat lung disease. ... Gaea Times (blog) US stock market opening report (December 18, 2009, Friday) - Dec 18, 2009 Food and Drug Administration has approved Spiriva HandiHaler for the reduction of exacerbations in patients with chronic obstructive pulmonary disease. ... Stock Markets Review Positive Earnings May Support a Rebound - Dec 18, 2009 Pfizer (PFE) could be in focus after it announced that the FDA has approved SPIRIVA handihaler, which is used for reduction of exacerbations in patients ... RTT News FDAæ ¸å‡†Tiotropium用於減少COPD惡化 - Dec 25, 2009 ...ã€?24drs.com】December 18, 2009 — 美國食å“?藥物管ç?†å±€(FDA)æ ¸å‡†å?¸å…¥åž‹é•·æ•ˆæŠ—膽鹼製劑tiotropium bromide (商å“?å??Spiriva HandiHaler，Boehringer Ingelheim ... 臺灣新浪網 í??ì§ˆí™˜ìš”ë²•ì œ '스피리바' ë‚ ê°œ 달았다 - Dec 19, 2009 ...주민우 기ìž? [헬스코리아뉴스] FDAê°€ ë² ë§?ê±° ì?¸ê²”하임과 í™”ì?´ìž?ì?˜ 만성í??쇄성 í??질환ì?˜ ìœ ì§€ìš”ë²•ì œ '스피리바(Spiriva Handihaler/tiotropium bromide inhalation ... 헬스코리아뉴스 ë² ë§?거잉겔하임 í??질환 치료 í?¡ìž…약, ì ?ì?‘ì¦? 추가 - Dec 21, 2009 ...김윤ì˜? 기ìž? FDA는 ë² ë§?거잉겔하임 ë°? í™”ì?´ìž?ê°€ ì‹ ì²í•œ 스피리바 핸디헤ì?¼ëŸ¬ í?¡ìž… 분ë§?ì œ(Spiriva HandiHaler: tiopropium bromide inhalation powder)ì—? 대go 만성 ... 메디포뉴스 Brand Name: Spiriva - Nov 11, 2009 Spiriva is used to make breathing easier for people with conditions such as chronic obstructive pulmonary disease (COPD), bronchitis and emphysema. ... Pattaya Daily News BEN column — Everybody helps CRHS Booster Golf; Warren Robinson questions ... - Nov 2, 2009 ...“Cough is almost non-existent, and as of yesterday, I'm not using my inhaler or Spiriva HandiHaler. Amazing difference in me and this is only a short time ... NJ.com Spiriva HandiHaler May Increase Stroke Risk - Mar 19, 2008 Spiriva HandiHaler, a treatment for chronic obstructive pulmonary disease (COPD), could increase the risk of stroke, the Food & Drug Administration (FDA) ... Newsinferno.com Spiriva HandiHaler.(Drug overview) - Jan 22, 2007 Spiriva is used for the long-term, once-a-day treatment of bronchial spasms (wheezing) associated with chronic obstructive pulmonary disease, ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com FDA Cautions on COPD Inhaler and Stroke Risk - Mar 18, 2008 The agency said that German drug maker Boehringer Ingelheim, which manufactures Spiriva HandiHaler, reported that ongoing safety monitoring identified a ... Washington Post Ohio subsidiary of German drugmaker completes expansion. - Apr 29, 2005 Roxane, the North American manufacturer for Germany-based Boehringer Ingelheim, recently began making Spiriva HandiHaler at its Wilson Road plant for export ... Free with registration - Columbus Dispatch - AccessMyLibrary.com Spiriva HandiHaler. - Apr 1, 2008 Spiriva HandiHaler. Boehringer Ingelheim has informed FDA of a potentially increased risk of stroke among patients treated with tiotropium (Spiriva ... $9.94 - Formulary - Alacra Store Article: The FDA ruled.(Update) - Medical Marketing & Media |... - Jul 1, 2006 Spiriva Handihaler (tiotropium bromide inhalation powder, Boehringer Ingelheim) An inhaled ... Article: FDA Approves Spiriva HandiHaler for the Treatment . ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Federal Register 2006 - 71 FR 4592 Determination of Regulatory Review... - Jan 27, 2006 71 FR 4592 Determination of Regulatory Review Period for Purposes of Patent Extension; SPIRIVA HANDIHALER January 27, 2006 [Docket No. ... Pay-Per-View - Federal Register 2006 - Loislaw Established Safety Profile of Spiriva Confirmed by 30 Rigorously - Sep 23, 2008 About Spiriva(R)HandiHaler(R) Spiriva HandiHaler is a once-daily inhaled maintenance prescription treatment for breathing problems (airway narrowing) ... Bloomberg Atlanta health, diet and fitness news | ajc.com - Mar 19, 2008 The agency said that German drug maker Boehringer Ingelheim, which manufactures Spiriva HandiHaler, reported that ongoing safety monitoring identified a ... Atlanta Journal Constitution FDA issues Spiriva and Foradil advisory - Mar 3, 2008 The medications in the capsules are specifically designed to be inhaled through the Spiriva HandiHaler and Foradil Aerolizer inhalation devices to improve ... United Press International Spiriva Improved Lung Function in COPD Patients of African Descent. - May 21, 2006 Spiriva HandiHaler is a once-a-day, regular (maintenance) treatment for bronchospasm ... (10) Spiriva HandiHaler (tiotropium bromide inhalation powder) ... Free with registration - PR Newswire - AccessMyLibrary.com Chronic obstructive pulmonary disease.(DRUG UPDATE) - May 1, 2005 ...bromide no generic one 18-mcg capsule inhalation powder available inhaled daily [Spiriva Handihaler] [$4.00] COMBINATION AGENTS albuterol/ipratropium no ... Free with registration - Internal Medicine News - AccessMyLibrary.com Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) … - Oct 5, 2008 SPIRIVA HandiHaler is a once-daily inhaled maintenance prescription treatment for breathing problems (airway narrowing) associated with chronic obstructive ... Genetic Engineering News - Genetic Engineering News (press release) Glaxo's Advair Lowers Death Risk in Smoker's Cough - Dec 28, 2007 ...the risk of death in people with a lung condition caused by smoking more than Boehringer Ingelheim GmbH's Spiriva HandiHaler, according to a new study. ... Bloomberg Drug Firms' Touch Light at Disease Talk - May 6, 2005 But it was sponsored by Boehringer Ingelheim Pharmaceuticals and Pfizer, drug firms promoting the Spiriva HandiHaler, a newly approved treatment for chronic ... RedOrbit Study: Inhaler Drugs Tied to Heart Problems, Deaths - Sep 24, 2008 The drugs are tiotropium, sold as Spiriva Handihaler by Boehringer Ingelheim Pharmaceuticals, Inc., and ipratropium, available generically and also sold by ... FOXNews Boehringer Ingelheim Pharma acquires Johnson & Johnson Inc-Zantac … - Oct 31, 2006 PFIZER CANADA INC-COMPANY INSIGHT · PFIZER CANADA INC-COMPANY INSIGHT, Life Science Analytics, Apr 16 2008, $2160.00 …marketed as Spiriva HandiHaler by ... Pay-Per-View - deals - Alacra Store Article: Chronic obstructive pulmonary disease.(Drug Update) - Skin &... - May 1, 2005 Once-a-day dosing an enormous [Spiriva Handihaler]advantage over other medications, such as ipratropium, which is dosed q.i.d. and is less cost effective. ... Pay-Per-View - Skin & Allergy News - HighBeam Research Established Safety Profile Of Spiriva Confirmed By 30 Rigorously … - Sep 27, 2008 Spiriva HandiHaler is a once-daily inhaled maintenance prescription treatment for breathing problems (airway narrowing) associated with chronic obstructive ... Medical News Today - Medical News Today (press release) Journals gather momentum: medical/surgical journals continued to show... - Apr 1, 2005 Spiriva HandiHaler, a new product for chronic obstructive pulmonary disease (COPD) that is marketed jointly by Pfizer/Boehringer Ingelheim, ranked 16th, ... $20.00 - Medical Marketing & Media - Alacra Store Chronic obstructive pulmonary disease.(DRUG UPDATE) | Article from … - May 1, 2005 ...no generic one 18-mcg capsule inhalation powder availableinhaled daily [Spiriva Handihaler] [$4.00] COMBINATION AGENTS albuterol/ipratropiumno generic 2 ... Pay-Per-View - Internal Medicine News - HighBeam Research Chronic obstructive pulmonary disease.(Drug Update) | Article from … - May 1, 2005 ...capsule inhalation powder availableinhaled daily [Spiriva Handihaler][$4 ... dosing an enormous advantage over [Spiriva Handihaler]other medications, ... Pay-Per-View - Family Practice News - HighBeam Research Data show no stroke risk with Pfizer lung drug-FDA - Oct 7, 2008 Spiriva HandiHaler aims to treat chronic obstructive pulmonary disease, or COPD, and is co-marketed by Pfizer (nyse: PFE - news - people ) and Boehringer ... Forbes Warning Sounded Over Incorrect Use Of 2 Asthma Drugs - Apr 27, 2005 Spiriva HandiHaler was approved in January 2004 for the scheduled, maintenance treatment of asthma and chronic obstructive pulmonary disease. Subscription - Wall Street Journal Online - Dow Jones & Company Atlanta health, diet and fitness news | ajc.com - Mar 1, 2008 The Spiriva HandiHaler and the Foradil Aerolizer are prescribed to people with asthma and other chronic respiratory diseases, the Associated Press reported. ... Atlanta Journal Constitution Press Release: SPIRIVA(R) Significantly Improves Lung Function in … - Sep 5, 2006 Article: FDA Approves Spiriva HandiHaler for the Treatment of ... PR Newswire; February 2, 2004 ; 700+ words ... ... the primary reversible component of ... Pay-Per-View - PR Newswire Europe - HighBeam Research On the level: medical/surgical journal publishers must wait a little... - Apr 1, 2007 Others dropping out of the top group include Ambien, Boniva, Ketek, Actos, Tarceva and Spiriva HandiHaler. SSRI/SNRI's remained the most heavily advertised ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com Changes in inhaler devices for asthma and COPD.(Nursing … - Jun 1, 2005 The Spiriva Handihaler[R] is a DPI device which includes a spherical covered plastic chamber and foil blister card of Spiriva[R] capsules. ... $4.95 - MedSurg Nursing - ECNext FDA Issues Spiriva and Foradil Advisory - Mar 4, 2008 The medications in the capsules are specifically designed to be inhaled through the Spiriva HandiHaler and Foradil Aerolizer inhalation devices to improve ... Money Times - The Money Times Press Release: A Meta-Analysis of Clinical Studies Shows: SPIRIVA(R) ... - May 23, 2006 Article: FDA Approves Spiriva HandiHaler for the Treatment of ... PR Newswire; February 2, 2004 ; 700+ words ... ... the primary reversible component of ... Pay-Per-View - PR Newswire Europe - HighBeam Research Novel soft mist COPD inhaler set for EU - Jul 26, 2007 ...dose therefore requiring two puffs), with therapeutic effect comparable to the 18 microgram Spiriva HandiHaler, the drug's current delivery device. ... In-PharmaTechnologist.com Drug lowers death risk in smoker's cough, study says - Dec 31, 2007 ...the risk of death in people with a lung condition caused by smoking more than Boehringer Ingelheim GmbH's Spiriva HandiHaler, according to a new study. ... China Post FDA: Don't Swallow Inhaler Capsules - Feb 29, 2008 The agency warned that these products will only properly assist breathing if inhaled through the Spiriva HandiHaler or Foradil Aerolizer, ... San Francisco Chronicle Ohio subsidiary of German drugmaker completes expansion. | Article... - Apr 29, 2005 Roxane, the North American manufacturer for Germany-based Boehringer Ingelheim, recently began making Spiriva HandiHaler at its Wilson Road plant for export ... Pay-Per-View - Columbus Dispatch - HighBeam Research The FDA ruled.(Update) - Jul 1, 2006 The FDA ruled that a promotional piece for Boehringer Ingelheim's Spiriva HandiHaler omitted material facts by indicating that Atrovent's inhalation aerosol ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com Tough losses: medical/surgical journals ad spend declines by 5% and … - Oct 1, 2007 ...increased by ... third even though ad outlays increased by ... following heavy ad outlays for Spiriva HandiHaler ... in medical/surgical journals. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research A promotional piece.(Update) | Article from Medical Marketing & Media... - May 1, 2007 The FDA ruled that a promotional piece for Boehringer Ingelheim's Spiriva HandiHaler omitted material facts by indicating that Atrovent's inhalation aerosol ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Inhaler risk cited - Sep 24, 2008 The drugs are tiotropium, sold as Spiriva Handihaler by Boehringer Ingelheim Pharmaceuticals, Inc., and ipratropium, available generically and also sold ... Pay-Per-View - Richmond Times - Dispatch - ProQuest Archiver Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, May 26 (DDMAC) … - Jun 1, 2006 DDMAC objected to a promotional piece for Spiriva Handihaler (tiotropium bromide inhalation powder) in that the four-page promotional piece was misleading ... $4.95 - Warning Letter Bulletin - ECNext New drug update 2004--part 3. - Mar 7, 2005 Spiriva HandiHaler FDA rating: 1-S (S = standard review) Tiotropium bromide is a quaternary ammonium derivative similar to ipratropium with the advantage of ... $9.94 - Drug Topics - Alacra Store Full Issue - May 30, 2006 The FDA notified Boehringer Ingelheim May 25 that a four-page promotional piece for its Spiriva Handihaler was "misbranded" because if failed to reveal ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones Starwatch Consumer: Pills in fish; recall notices - Mar 19, 2008 ...by the German drugmaker Boehringer Ingelheim show a slightly higher rate of stroke for patients using its Spiriva Handihaler, compared with a placebo. ... $2.95 - Kansas City Star - NewsBank FDA Cites Company for 'Misleading' Promotion of Inhalant - May 30, 2006 The FDA notified Boehringer Ingelheim May 25 that a four-page promotional piece for its Spiriva Handihaler was "misbranded" because if failed to reveal ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones Pfizer.(Phase IV) - Jul 1, 2005 Pfizer's (New York, NY) Spiriva HandiHaler (tiotropium bromide inhalation powder) for nine months improved QOL for patients with COPD, a postmarketing study ... Free with registration - Applied Clinical Trials - AccessMyLibrary.com Inhaler drugs may raise risk of heart attacks - Sep 27, 2008 The drugs are tiotropium, sold as Spiriva Handihaler by Boehringer Ingelheim Pharmaceuticals Inc. and ipratropium, available generically and also sold by ... $2.95 - Lexington Herald Leader - NewsBank Article: Journals gather momentum: medical/surgical journals continued... - Apr 1, 2005 Pfizer/Boehringer Ingelheim (which climbed from 149th to 22nd following heavy ad outlays for Spiriva HandiHaler), Lilly Icos (which jumped from 898th to ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Finaliza el proceso de aprobación en Europa del nuevo inhalador … - Jul 26, 2007 26 DE JULIO DE 2007 – Boehringer Ingelheim y Pfizer anuncian que ha concluido satisfactoriamente el proceso para obtener la autorización de comercialización ... acceso.com Spiriva use for chronic obstructive pulmonary disease tied to... - Apr 15, 2008 The company submitted the data from 25 studies of the Spiriva HandiHaler, and four trials of Spiriva Respimat, the formulation marketed in Europe. ... Pay-Per-View - Family Practice News - HighBeam Research The 10 Weirdest Drug Stories of the Month - Nov 3, 2008 This time the company has its hopes up for the Spiriva Handihaler, a treatment for chronic obstructive pulmonary disease. Spiriva sustained improvements in ... BNET ALSO NOTED: GSK faces Tyverb setback over safety; Boehringer warns … - Mar 19, 2008 Boehringer Ingelheim warned regulators that patients using its respiratory inhaler Spiriva Handihaler face a greater risk of stroke. ... FiercePharma Medicare Part D looms; ongoing fallout from Vioxx - Jul 21, 2005 3/8/04. Pemetrexed disodium. Alimta. Eli Lilly. PV. 2/4/04. Tiotropium bromide. Spiriva Handihaler. Boehringer Ingelheim. S. 1/30/04. P-Priority review: signif. $295.00 - Industry Surveys - Standard & Poor's Press Release: Finalists Announced For the Fourth Annual … - May 11, 2005 PHARMACEUTICAL MARKETING CATEGORY Product Launch of the Year Boehringer Ingelheim Pharmaceuticals Inc.: Spiriva HandiHaler Cubist Pharmaceuticals, ... Pay-Per-View - PR Newswire - HighBeam Research Hayes v. Astrue, No. 4:06 CV 1731 DDN (EDMo. 02/25/2008) - Feb 25, 2008 ...[49], On July 3, 2006, Hayes was taking Abreva and Valtrex for cold sores, Advair, Albuterol, and Spiriva Handihaler for emphysema, Allegra and Singulair ... $2.95 - U.S. District Court, Eastern District... - VersusLaw Inhaler lung drugs tied to heart problems, deaths - Nov 17, 2008 The drugs are tiotropium, sold as Spiriva Handihaler by Boehringer Ingelheim Pharmaceuticals Inc., and ipratropium, available generically and also sold by ... $2.95 - Daily Herald - NewsBank Drug Development; Atrovent HFA now available for COPD patients - Jun 21, 2005 In June of 2004, the company launched Spiriva HandiHaler (tiotropium bromide inhalation powder), the first once-daily inhaled medication to provide ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Montelukast acts rapidly to prevent bronchospasm.(Pulmonary Medicine)... - Jun 15, 2005 The Spiriva HandiHaler (tiotropium inhalation powder), a long-acting anticholinergic ... Internal Medicine News. Article: Residents' Hours Put Students on ... Pay-Per-View - Internal Medicine News - HighBeam Research Posts Warning About Accidental Misuse of Two Asthma Rx - Apr 28, 2005 Thirty of the reports involved Foradil Aerolizer, manufactured by Novartis, and two involved Spiriva HandiHaler, manufactured by Boehringer Ingelheim, ... Pay-Per-View - American Health Line - Factiva, from Dow Jones Drug Development; Atrovent HFA now available for COPD patients - Jun 20, 2005 In June of 2004, the company launched Spiriva HandiHaler (tiotropium bromide inhalation powder), the first once-daily inhaled medication to provide ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Inhaler lung drugs tied to heart problems, deaths.(Health Fitness)(Cli... - Nov 17, 2008 The drugs are tiotropium, sold as Spiriva Handihaler by Boehringer Ingelheim Pharmaceuticals Inc., and ipratropium, available generically and also sold by ... Pay-Per-View - Daily Herald - HighBeam Research Avviso FDA sul tiotropio - Mar 25, 2008 Tiotropio un possibile aumento del rischio di ictus tra i malati di BPCO (broncopneumopatia cronica ostruttiva) in terapia con Spiriva HandiHaler (tiotropio ... Pharma Marketing BPCO: il farmaco Spiriva associato a rischio di ictus ? - May 21, 2008 In 25 studi clinici, i pazienti sono stati trattati con Spiriva HandiHaler. Negli altri 4 studi clinici, i pazienti sono stati trattati con un'altra ... XagenaSalute BPCO: maggiore broncodilatazione precoce per il Formoterolo rispetto... - Apr 28, 2006 E' stato valutato l'effetto di 7 giorni di trattamento con Formoterolo ( 12mg bid di Foradil Aerolizer ) versus Tiotropio ( 18mg od di Spiriva HandiHaler ... XagenaSalute Inhaler naikkan risiko serangan jantung - Sep 24, 2008 Obat yang dimaksud adalah tiotropium, yang dijual oleh Spiriva Handihaler buatan Boehringer Ingelheim Pharmaceuticals Inc, serta ipratropium yang dijual ... Bisnis Indonesia Boehringer Ingelheim и Pfizer Inc. доказывают профиль безопаÑ?ноÑ?ти … - Oct 3, 2008 включаÑ? UPLIFT, подтвердившего профиль безопаÑ?ноÑ?ти в долгоÑ?рочной перÑ?пективе препарата Spiriva HandiHaler (тиотропиум бромида порошок длÑ? ингалÑ?ции). ... ФармацевтичеÑ?кий веÑ?тник åˆ?æœŸç ”ç©¶çµ?果：Spiriva與ä¸é¢¨é¢¨éšªå¢žåŠ ç„¡é—œ - Oct 8, 2008 ...了將近6000ä½?ç—…æ‚£çš„ç ”ç©¶çµ?果顯示，相較於安慰劑，使用å?¸å…¥æ€§çš„長效抗膽鹼激性 藥物tiotropium bromide（Spiriva Handihalerï¼Œç™¾é½¡ä½³è—¥å» è´ŠåŠ©ï¼‰ä¸¦ä¸?æœƒå¢žåŠ ä¸é¢¨é¢¨éšªã€‚ ... udn.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |